| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Eijkman-Winkler Institute, University Medical Center Utrecht, Utrecht, The Netherlands; and
Department of Cell Biology and Physiology, University of New Mexico Health Science Center, Albuquerque, NM 87131
Chemotaxis inhibitory protein of Staphylococcus aureus (CHIPS) is an exoprotein produced by several strains of S. aureus, and a potent inhibitor of neutrophil and monocyte chemotaxis toward C5a and formylated peptides like fMLP. These chemoattractants act on their target cells by binding and activating the C5aR and formylated peptide receptor (FPR), respectively. In the present report, we examined the mechanism by which CHIPS affects both of these receptors. We showed that CHIPS blocked binding of anti-C5aR mAb and formylated peptide to human neutrophils as efficiently at temperatures of 0 and 37°C, implying that it is independent of signal transducing systems. This was confirmed by showing that CHIPS acts completely independently of ATP. Additionally, CHIPS was not internalized upon binding to neutrophils. Furthermore, we showed that CHIPS binds specifically to the C5aR and FPR expressed on U937 cells. This binding was functional in blocking C5a- and fMLP-induced calcium mobilization in these cell lines. These results suggest that CHIPS binds directly to the C5aR and FPR, thereby preventing the natural ligands from activating these receptors. The apparent Kd values of CHIPS for the C5aR and FPR were 1.1 ± 0.2 nM and 35.4 ± 7.7 nM, respectively. Moreover, after screening a wide variety of other G protein-coupled receptors, CHIPS was found to affect exclusively the C5aR and FPR. This selectivity and high-affinity binding with potent antagonistic effects makes CHIPS a promising lead for the development of new anti-inflammatory compounds for diseases in which damage by neutrophils plays a key role.
This article has been cited by other articles:
|
|
 |
|
  A. Upadhyay, J. D. Burman, E. A. Clark, E. Leung, D. E. Isenman, J. M. H. van den Elsen, and S. Bagby Structure-Function Analysis of the C3 Binding Region of Staphylococcus aureus Immune Subversion Protein Sbi J. Biol. Chem., August 8, 2008; 283(32): 22113 - 22120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Ramsland, N. Willoughby, H. M. Trist, W. Farrugia, P. M. Hogarth, J. D. Fraser, and B. D. Wines Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1 PNAS, September 18, 2007; 104(38): 15051 - 15056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. M. Rooijakkers, F. J. Milder, B. W. Bardoel, M. Ruyken, J. A. G. van Strijp, and P. Gros Staphylococcal Complement Inhibitor: Structure and Active Sites J. Immunol., September 1, 2007; 179(5): 2989 - 2998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bestebroer, M. J. J. G. Poppelier, L. H. Ulfman, P. J. Lenting, C. V. Denis, K. P. M. van Kessel, J. A. G. van Strijp, and C. J. C. de Haas Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling Blood, April 1, 2007; 109(7): 2936 - 2943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Prat, J. Bestebroer, C. J. C. de Haas, J. A. G. van Strijp, and K. P. M. van Kessel A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 1 J. Immunol., December 1, 2006; 177(11): 8017 - 8026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. B. van Wamel, S. H. M. Rooijakkers, M. Ruyken, K. P. M. van Kessel, and J. A. G. van Strijp The Innate Immune Modulators Staphylococcal Complement Inhibitor and Chemotaxis Inhibitory Protein of Staphylococcus aureus Are Located on {beta}-Hemolysin-Converting Bacteriophages J. Bacteriol., February 15, 2006; 188(4): 1310 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Postma, W. Kleibeuker, M. J. J. G. Poppelier, M. Boonstra, K. P. M. Van Kessel, J. A. G. Van Strijp, and C. J. C. de Haas Residues 10-18 within the C5a Receptor N Terminus Compose a Binding Domain for Chemotaxis Inhibitory Protein of Staphylococcus aureus J. Biol. Chem., January 21, 2005; 280(3): 2020 - 2027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Y. L. Lee, X. Liang, M. Hook, and E. L. Brown Identification and Characterization of the C3 Binding Domain of the Staphylococcus aureus Extracellular Fibrinogen-binding Protein (Efb) J. Biol. Chem., December 3, 2004; 279(49): 50710 - 50716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-J. Haas, C. J. C. de Haas, W. Kleibeuker, M. J. J. G. Poppelier, K. P. M. van Kessel, J. A. W. Kruijtzer, R. M. J. Liskamp, and J. A. G. van Strijp N-Terminal Residues of the Chemotaxis Inhibitory Protein of Staphylococcus aureus Are Essential for Blocking Formylated Peptide Receptor but Not C5a Receptor J. Immunol., November 1, 2004; 173(9): 5704 - 5711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Haggar, C. Ehrnfelt, J. Holgersson, and J.-I. Flock The Extracellular Adherence Protein from Staphylococcus aureus Inhibits Neutrophil Binding to Endothelial Cells Infect. Immun., October 1, 2004; 72(10): 6164 - 6167. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
